on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 in compliance with the Irish Takeover Panel rules. This disclosure concerns The Vanguard Group's interests in Mural Oncology plc, specifically relating to relevant securities equating to 1% or more. The disclosure was made on October 8, 2025, with the position held on October 7, 2025.
As of the latest disclosure, The Vanguard Group, Inc. holds 288,827 ordinary shares of Mural Oncology plc, representing 1.67% of the relevant securities. In recent transactions, The Vanguard Group purchased 64 ordinary shares at $2.09 each and sold 16 shares at the same price.
No indemnity or gambling arrangements, or any similar agreements, have been entered into by The Vanguard Group in relation to Mural Oncology plc's securities. Similarly, there are no agreements concerning options or derivatives.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news